Explores how institutional investors should reconfigure portfolio allocations/strategies in a world of low returns.
Michael Cembalest analyzes the performance of over 6,700 domestic and international active equity managers, and discusses the challenges they face outperforming at a time of markets distorted by quantitative easing.
Eye on the Market: The Verdict
Armageddonists and the portfolio cost of fear, 2010-2019
Michael discusses his forecast for 2020, which entails a modest recovery in global growth and profits after trade-war weakness in 2019.
An update from the front lines of the Trade War, with a focus on implications for investors
Answers to questions on the coronavirus, US megacap stocks, the cost of Democratic Healthcare plans, the Iowa caucus and the problem with the student loan system.
In this special holiday edition, Michael explains how an evening at home went awry: how a discussion about China and Hong Kong morphed into a chart war about Trump, Hoover, Taft, Rachel Maddow and Anderson Cooper.
Michael shares his thoughts on the US China trade war, Mexico tariffs and the US immigration policy.
A close look at the Progressive Agenda, China’s deteriorating welcome mat in DC and US Tech IPOs.